Introduction

Uses of Xenogrow 2%

Hair loss
Hypertension (high blood pressure)

Side effects of Xenogrow 2%

Excessive hair growth on face
Rash
Edema (swelling)
Skin irritation

How to use Xenogrow 2%

Use this medicine in the dose and duration as advised by your doctor. Check the label for directions before use.

How Xenogrow 2% works

Xenogrow 2% is a potassium channel opener. Its vasodilation action expands the blood vessels. Therefore, when it is applied to the scalp, it helps to increase the blood flow. This increased blood flow provides more nutrition and oxygen to the hair follicles, which prevents hair cell death and also enhances new hair growth. This is how it works to treat your alopecia (hair loss).

What if you forget to take Xenogrow 2%?

If you miss a dose of Xenogrow 2%, apply it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

Quick Tips

Wash your hands before and after application.
It should only be applied directly on the scalp. If MX 5 Topical Solution accidentally comes in contact with your eyes, nose or mouth, flush the area thoroughly with cool tap water.
Do not shampoo your hair or use a hairdryer for 4 hours after applying MX 5 Topical Solution as it can reduce the effectiveness of the medicine.
During the first 2 weeks of application, your hair fall may increase. This is normal and is a sign that MX 5 Topical Solution is working.
Take care that MX 5 Topical Solution does not trickle down onto your face as it may cause undesirable facial hair growth.

Safety Advice

– Alcohol: No interaction found/established
CONSULT YOUR DOCTOR – Pregnancy: Xenogrow 2% may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
SAFE IF PRESCRIBED – Breastfeeding: Xenogrow 2% is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
– Driving: No interaction found/established
– Kidney: No interaction found/established
– Liver: No interaction found/established